Global /United States /Financial Services /Financial Conglomerates /USAQ
chevron_leftBack
QHSLab, Inc. logo

QHSLab, Inc.

USAQ
OTCMKTS: USAQ Delayed
0.5480USD -17%
As of 13 June 2026, QHSLab, Inc. has a market cap of $3.76M USD, ranking #45472 globally and #5775 in the United States. It ranks #4525 in the Financial Services sector, and #817 in the Financial Conglomerates industry.
Global Rank
45472
Country Rank
5775
Sector Rank
4525
Industry Rank
817
Key Stats
Market Cap
$3.76MUSD
Enterprise Value
$7.89MUSD
Revenue (TTM)
$2.69MUSD
EBITDA (TTM)
$203.36KUSD
Net Income (TTM)
$457.42KUSD
EBITDA Margin
7.6%
Profit Margin
17%
PE Ratio
27.4
PS Ratio
3.1
PB Ratio
5.1
EV/EBITDA
38.8
Company Profile
Country (HQ)
Sector
Financial Services
Industry
Financial Conglomerates
CEO
Troy Grogan open_in_new
Employees
12
Founded
1983
Website
qhslab.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-17% -8.7% -3.9% -32% 149% 189%

News

Loading...

Markets

Exchange Ticker Price
OTC Markets
MIC: OTCM
PRIMARY
USAQ
QHSLab Inc Class A
ISIN: US90350R1077
Shares Out.:
15.033M1 Shares Float: 6.639M2
TV:
SA:
YF:
GF:
BA:
MS:
0.5480 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About QHSLab, Inc.

QHSLab, Inc., a medical device technology and software-as-a-service (SaaS) company, provides tools to evaluate and treat chronic disease and preventive care through reimbursable procedures. The company focuses on value-based healthcare, informatics, and algorithmic personalized medicine, including digital therapeutics, behavior based remote patient monitoring, and chronic care and preventive medicine. Its digital healthcare and clinical decision support and point of care solutions also support non face to face remote patient and therapeutic monitoring, address chronic care, and preventive medicine. The company provides quality health score lab expert system (QHSLab), a cloud-based medical office and mobile patient education solution that provides physicians with dashboard to streamline patient information and business operations; and AllergiEnd, a diagnostic and allergen immunotherapy system for the busy non-allergist in a primary care setting. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. The company was incorporated in 1983 and is based in West Palm Beach, Florida.

Similar Companies

Industry: Financial Conglomerates (United States)
Name
Market Cap diff.
PE
ARCC
$13.41B
357K%
11.5
$6.77B
9.46B CAD
180K%
-
$5.6B
149K%
9.1
$5.22B
139K%
28.7
$4.84B
129K%
9.7
$3.51B
93K%
10.7
Industry: Financial Conglomerates (Global)
Name
Market Cap diff.
PE
INVE-A
$120.04B
1.14T SEK
3M%
5.9
402340
$71.97B
109.46T KRW
2M%
12.5
ITSA3
$30.93B
157.1B BRL
823K%
9.5
$21.94B
207.94B SEK
584K%
5.2
$18.94B
598.03B TWD
504K%
12.6
HAL
$17.79B
15.4B EUR
473K%
9.6
chevron_leftBack